Experimental Cerebral Infarction: Modification by Treatment with Hemodiluting, Hemoconcentrating, and Dehydrating Agents

Abstract

tran, has been used to treat experimental cerebral infarction in dogs, with somewhat favorable results. ~ In this paper we shall report the results of the modification of cerebral infarction in cats by a variety of agents. The agents include: hyperoncotic solutions of low-molecular-weight dextran, serum albumin, and urea, individually and in combination; honmlogous serum; physiologic saline; and packed erythrocytes.